Propafenone inhibition of human atrial myocyte repolarizing currents

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 4, 1998, Pages 783-793

  Gross, Gil J ^a,b,c,d   Castle, Neil A ^b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

Antiarrhythmic agents; Human atrial myocytes; Propafenone; Repolarization; Transient outward current

Indexed keywords

ANTIARRHYTHMIC AGENT; PROPAFENONE;

ACCELERATION; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; HEART ATRIUM MUSCLE; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART REPOLARIZATION; HUMAN; HUMAN CELL; MALE; NEWBORN; PATCH CLAMP; PRIORITY JOURNAL;

EID: 0032054671     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0643     Document Type: Article

References (25)

1. DELGADO C, TAMARGO J, TEJERINA T, 1985. Electrophysiological effects of propafenone in untreated and propafenone-pretreated guinea-pig atrial and ventricular muscle fibres. Br J Pharmacol 86: 765-775.
2. DELGADO C, TAMARGO J, TEJERINA T, VALENZUELA C, 1987. Effects of 5-hydroxy-propafenone in guinea-pig atrial fibres. Br J Pharmacol 90: 575-582.
3. + current in guinea pig ventricular myocytes: voltage-independent and time-independent block of the slowly activating component. Circ Res 76: 223-235.
4. DUAN D, FERMINI B, NATTEL S, 1993. Potassium channel blocking properties of propafenone in rabbit atrial myocytes. J Pharmacol Exp Ther 264: 1113-1123.
5. FERMINI B, WANG Z, DUAN DY, NATTEL S, 1992. Differences in rate dependence of transient outward current in rabbit and human atrium. Am J Physiol 263: H1747-H1754.
6. GRANT AO, 1996. Propafenone: an effective agent for the management of supraventricular arrhythmias. J Cardiovasc Electrophysiol 7: 353-364.
7. GROSS GJ, BURKE RP, CASTLE NA, 1995. Characterisation of transient outward current in young human atrial myocytes. Cardiovasc Res 29: 112-117.
8. HAMILL OP, MARTY A, NEHER E, SAKMANN B, SIGWORTH FJ, 1981. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 391: 85-100.
9. MALEATTO G, ZAZA A, FORSTER M, SODOWICK B, DANILO P JR, ROSEN MR, 1988. Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone. J Pharmacol Exp Ther 246: 419-426.
10. MUSTO B, D'ONOERIO A, CAVALLARO C, MUSTO A, 1988. Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia. Circulation 78: 863-869.
11. NÄBAUER M, BEUCKELMANN DJ, 1992. Block of transient outward current by Class Ic antiarrhythmic agents propafenone and flecainide in human ventricular myocytes (Abstract). Circulation 86: 1-697.
12. PAUL T, JANOUSEK J, 1994. New antiarrhythmic drugs in pediatric use: propafenone. Pediatr Cardiol 15: 190-197.
13. REIMOLD SC, CANTILLON CO, FRIEDMAN PL, ANTMAN EM, 1983. Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. Am J Cardiol 71: 558-563.
14. + channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes. J Pharmacol Exp Ther 269: 66-74.
15. SNYDERS DJ, YEOLA SW, 1995. Determinants of antiarrhythmic drug action: electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel. Circ Res 77: 575-583.
16. SNYDERS DJ, KNOTH KM, ROBERDS SL, TAMKUN MM, 1992. Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel. Mol Pharmacol 41: 322-330.
17. SPACH MS, DOLBER PC, ANDERSON PAW, 1989. Multiple regional differences in cellular properties that regulate repolarization and contraction in the right atrium of adult and newborn dogs. Circ Res 65: 1594-1611.
18. STANTON MS, 1995. Class I antiarrhythmic drugs: quinidine, procainamide, disopyramide, lidocaine, mexiletine, tocainide, phenytoin, moricizine, flecainide, propafenone. In: Zipes DP and Jalife J (eds). Philadelphia, PA: W. B. Saunders, 1296-1317.
19. VILLAFANE J, GELBAND H, XU H, MCCORMACK J, STOLFI A, PICKOFF AS, 1987. The electrophysiologic effects of propafenone hydrochloride in the neonatal canine. Pediatr Res 22: 50-54.
20. WANG Z, PELLETIER LC, TALAJIC M, NATTEL S, 1990. Effects of flecainide and quinidine on human atrial action potentials: role of rate-dependence and comparison with guinea pig, rabbit, and dog tissues. Circulation 82: 274-283.
21. WANG Z, FERMINI B, NATTEL S, 1993a. Delayed rectifier outward current and repolarization in human atrial myocytes. Circ Res 73: 276-285.
22. + current similar to Kv1.5 cloned channel currents. Circ Res 73: 1061-1076.
23. WANG Z, FERMINI B, NATTEL S, 1994. Rapid and slow components of delayed rectifier current in human atrial myocytes. Cardiovasc Res 28: 1540-1546.
24. WANG Z, FERMINI B, NATTEL S, 1995. Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes. J Pharmacol Exp Ther 272: 184-196.
25. YAMASHITA T, NAKAJIMA T, HAMADA E, HAZAMA H, OMATA M, KURACHI Y, 1995. Flecainide inhibits the transient outward current in atrial myocytes isolated from the rabbit heart. J Pharmacol Exp Ther 274: 315-321.